Safety And Efficacy Of Oral Agents In R/R Dlbcl

Safety and Efficacy of Oral Agents in R/R DLBCL

Glofitamab in R/R DLBCL: updated safety and efficacy data

VJHemOnc – Video Journal of Hematology & HemOnc

Safety and Efficacy of CAR T Therapy in R/R DLBCL

Safety and efficacy of rapcabtagene autoleucel (YTB323), a CAR T-cell therapy, in r/r DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Efficacy and safety of M-Pola for R/R B-cell NHL

VJHemOnc – Video Journal of Hematology & HemOnc

Safety and efficacy of MB-106 for the treatment of R/R FL

VJHemOnc – Video Journal of Hematology & HemOnc

Safety and Efficacy of BTK Inhibitors in R/R MCL

Targeted Oncology

Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Lymphoma Research Foundation

Real-world efficacy & safety data: CAR-T in DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Key novel agents for relapsed diffuse large B-cell lymphoma

BCR Inhibitors in CLL and Lymphoma

The safety and efficacy of acalabrutinib for the treatment of R/R MZL

VJHemOnc – Video Journal of Hematology & HemOnc

Safety and efficacy of plamotamab in the treatment of non-Hodgkin lymphoma subtypes

VJHemOnc – Video Journal of Hematology & HemOnc

Clinical efficacy and safety of CT-P10 in patients with DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Real-world efficacy & safety data: CAR-T in DLBCL

The role of ibrutinib in DLBCL and the value of next-generation BTK inhibitors

VJHemOnc – Video Journal of Hematology & HemOnc

Comparing the efficacy and curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

15-year follow-up of SWOG-S0016: achieving a functional cure in a subset of patients with FL

VJHemOnc – Video Journal of Hematology & HemOnc

Efficacy and safety of sonrotoclax in B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Safety and efficacy of pirtobrutinib in patients with R/R B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc